Luncheon Seminar

LS1-13

The potential of HEMLIBRA® for hemophilia A patients with inhibitors.

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Satoshi Higasa (Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan)

Sponsor: Chugai Pharmaceutical Co., Ltd.

Luncheon Seminar

LS1-14

Management of invasive fungal infections after HSCT

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Shuichi Taniguchi (Department of Hematology, Toranomon Hospital)

Sponsor: Pfizer Japan Inc.

Luncheon Seminar

LS1-15

Novel treatment strategies for indolent NHL

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Kiyoshi Ando (Department of Hematology and Oncology, Tokai University School of Medicine)

Sponsor: Celgene K. K.

Luncheon Seminar

LS2-1

Novel Treatment for Newly Diagnosed Multiple Myeloma

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.1 (Osaka International Convention Center, 5F Main Hall)

Chair: Hiroshi Handa (Department of Hematology, Gunma University Graduate School of Medicine)

Sponsor: Celgene K.K.

Luncheon Seminar

LS2-3

Updates on treatment of Hodgkin Lymphoma

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Hirohiko Shibayama (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Sponsor: TAKEDA PHARMACEUTICAL Company Limited

Luncheon Seminar

LS2-4

Learn from experts’ daily practice - AA and ITP for better outcome-

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Yuzuru Kanakura (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Sponsor: Novartis Pharma K.K.

Luncheon Seminar

LS2-5

Therapeutic challenges in lower-risk MDS

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Yasushi Miyazaki (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)

Sponsor: Kyowa Hakko Kirin Co., Ltd.

Luncheon Seminar

LS2-6

Going the distance: Are we losing patients along the multiple myeloma treatment pathway?

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Junya Kuroda (Kyoto prefecture medical university)

Sponsor: Janssen Pharmaceutical K.K.

Luncheon Seminar

LS2-7

The role of Thalidomide in current Myeloma therapy - trials & real world data

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Kazuyuki Shimizu (National Hospital Organization Higashinagoya National Hospital)

Sponsor: Fujimoto Pharmaceutical Corp.

Luncheon Seminar

LS2-8

Molecular heterogeneity of DLBCL and its clinical impact

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Koichi Ohshima (Department of Pathology, Kurume University School of Medicine)